NCT02202746 2020-06-23A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast CancerClovis Oncology, Inc.Phase 2 Terminated178 enrolled 20 charts